 |
 Video: What is a Stock Split?
|
|
|
| Lannett primarily develops, manufactures, markets and distributes generic versions of brand pharmaceutical products. Co.'s key products include: Fluphenazine Tablets, which are used for the management of manifestations of psychotic disorders; Posaconazole DR Tablets, which are used to prevent fungal infections in people who have a weak immune system resulting from certain treatments or conditions; Verapamil SR Tablets, which are a calcium channel blocker used in the treatment of high blood pressure, arrhythmia and angina; and Methylphenidate CD Capsules, which are a central nervous system stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder. According to our LCI split history records, Lannett has had 1 split. |
|
|
Lannett (LCI) has 1 split in our LCI split history database. The split for LCI took place on March 03, 2003. This was a 3 for 2 split, meaning for each 2 shares of LCI owned pre-split, the shareholder now owned 3 shares. For example, a 1000 share position pre-split, became a 1500 share position following the split.
When a company such as Lannett splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business.
Looking at the LCI split history from start to finish, an original position size of 1000 shares would have turned into 1500 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Lannett shares, starting with a $10,000 purchase of LCI, presented on a split-history-adjusted basis factoring in the complete LCI split history.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
12/06/2010 |
|
| End date: |
12/04/2020 |
|
| Start price/share: |
$6.48 |
|
| End price/share: |
$6.78 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
4.63% |
|
| Average Annual Total Return: |
0.45% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$10,459.35 |
|
| Years: |
10.00 |
|
|
|
| Date |
Ratio |
| 03/03/2003 | 3 for 2 |
|
|
